BioChain Institute

BioChain Institute, Inc. recognizes Awareness month. Our aim is to support around the world achieve their goals. From the last 25 years our products and services have bolstered several projects.

The goal in now is to target care more precisely to patients through individualized health care. This is called , and it is an especially welcome change for cancer patients who traditionally have been exposed to treatment such as chemotherapy and radiation that attacks their cancer but often damages healthy tissue in the process.

In a study on mediated cancer immunotherapy by
Mary Litzinger – derived cDNAs, prepared from different individuals with different tumor types, were obtained from BioChain. American Association of Cancer Research

"Immunotherapeutic interventions against cancer depend on the identification of tumor antigens able to elicit a host immune response against the tumor cells" Read more: https://lnkd.in/ghuH3zdx

In this study bit.ly/3wRWtcD - Human DNAJB6 cDNA was synthesized from total isolated from normal human adult heart from BioChain Institute, Inc. https://lnkd.in/gMeV_B-A

Phenotypic variation occurs in many inherited human diseases, and as a result, has made it difficult to identify specific mechanisms and potential therapeutics. Reasons for phenotypic variation are difficult to distinguish, as differences could result from combinatory interactions among several causative genes (Deacon et al., 2019; Gifford et al., 2019) or co-existence of a causative gene and a Disease Models & Mechanisms • DMM • Accepted manuscript modifier gene. Due to higher throughput than most other vertebrate models, zebrafish possess unique advantages for developing new methods that enable the discovery of modifying genes.